ReviewNational science review2026
Biological conversion of methane to organic molecules: towards a low-carbon bioeconomy.
Review in National science review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in biotechnological methods for genetic and metabolic engineering in Methylomonas sp. DH-1.Journal of biological engineering · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increasing imperative to mitigate greenhouse gas emissions and foster the transition to a low-carbon bioeconomy has intensified interest in methane bioconversion as a sustainable approach for transforming methane into valuable bioproduction. Although advancements have been made in optimizing methanotrophic pathways to improve bioproduction, significant challenges persist, including methane solubility, bioavailability, and metabolic flexibility, limiting the efficiency of methane bioconversion. This review provides a comprehensive overview of the initiatives aimed at developing next-generation methanotrophic cell factories by overcoming the physiological limitations of natural methanotrophs. We first analyze the metabolic characteristics of methanotrophs for assimilating methane into cellular building blocks. Then, we discuss methane assimilation pathways and their unique characteristics in matter and energy transmission for facilitating the integration of methane into central carbon metabolism. Further, we propose a systematic framework for designing methane-based biomanufacturing to enable low-carbon bioproduction by integrating synthetic biology, metabolic engineering, and systems biology, thereby developing efficient methane assimilation cell factories for producing high-value bioproducts. Finally, we prospect the potential for valorizing methane derived from anthropogenic emissions and renewable sources, while identifying the key challenges and future research directions necessary for advancing a sustainable, low-carbon bioeconomy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.